Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 29, 2026
Microsoft (MSFT) Stock: +2.3% Recovery in 30 Days as Earnings Approach

Microsoft (MSFT) Stock: +2.3% Recovery in 30 Days as Earnings Approach

Key Takeaways

  • Microsoft shares have moved approximately +2.3% over the last 30 days, recovering from a June low near $349 but remaining well below the 50-day and 200-day moving averages.
  • The stock is down roughly 21% year-to-date, making it the second-worst performer among the "Magnificent Seven" in 2026, as AI infrastructure spending fears dominate sentiment.
  • Fiscal fourth-quarter earnings arrive July 29, with all eyes on Azure growth, Copilot adoption metrics, and fiscal 2027 capital expenditure guidance.
  • Analyst consensus remains overwhelmingly bullish with 42 Buy ratings and an average price target of approximately $555, implying more than 45% upside from current levels.
  • Institutional ownership stands at 71.13%, and several major funds increased their Microsoft positions during the most recent reporting quarter.

Where MSFT Stands in the Current Market

Microsoft shares closed at $381.70 on July 24, 2026, capping a period of cautious consolidation after the stock bounced from an intra-year low of $349.20 in late June. The 30-day gain of approximately 2.3% reflects a modest recovery rather than a decisive trend change. MSFT remains below its 50-day moving average of $398.21 and its 200-day moving average of $407.62, indicating persistent technical pressure. The broader context is a stock that has shed nearly 29% from its all-time high of $555.45, as investors grapple with the scale of Microsoft's AI infrastructure spending and the pace of returns on those investments. With a trailing P/E of 22.72, Microsoft trades well below its five-year average of roughly 32.5, a compression that reflects market skepticism about near-term margin trajectory and free cash flow generation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Microsoft's Business Overview and Competitive Position

Microsoft Corporation is the world's largest software company by revenue and the second-most valuable publicly traded company, with a market capitalization of approximately $2.84 trillion. The company operates through three primary segments: Productivity and Business Processes, which includes Microsoft 365, LinkedIn, and Dynamics 365; Intelligent Cloud, anchored by the Azure cloud platform and server products; and More Personal Computing, encompassing Windows, devices, gaming, and search advertising. Microsoft's competitive moat rests on deep enterprise penetration—over 450 million Microsoft 365 commercial seats—coupled with an AI strategy that spans infrastructure (Azure), platform (Foundry, Fabric), and applications (Copilot across Office, GitHub, and Security). The company's multi-year, $190-billion-plus annual commitment to AI data center buildout positions it as one of the three dominant hyperscale cloud providers alongside AMZN and GOOGL.

Recent Developments Driving MSFT

The 30-day window has been shaped primarily by positioning ahead of Microsoft's July 29 fiscal fourth-quarter earnings report. Several analysts adjusted price targets while maintaining bullish ratings: Morgan Stanley lowered its target to $600 from $650, citing near-term margin pressure but arguing the market underestimates Azure's second-half acceleration potential. Citi reduced its target to $570 while keeping a Buy rating, and Mizuho trimmed to $490 with an Outperform rating—both firms flagging capex digestion as the primary investor concern.

On the strategic front, Microsoft joined 25 technology companies urging U.S. policymakers not to impose broad restrictions on open-weight and open-source AI models, a stance that supports its multi-model ecosystem strategy. The company also expanded its partnership with Databricks through the 2030s, reinforcing Azure's enterprise AI data pipeline. Additionally, Microsoft completed a reorganization eliminating approximately 4,800 roles, primarily in non-core areas such as gaming, as part of its AI-focused realignment.

Headline risk emerged from multiple law firms issuing securities class-action alerts tied to Copilot-related disclosures, though these have not materially altered analyst consensus. The stock's price action has been heavily influenced by broader sector dynamics: the "Magnificent Seven" collectively sold off sharply in mid-July after GOOGL reported negative free cash flow and raised capex guidance, triggering a spillover effect across all mega-cap AI spenders, including Microsoft. To get a broader view on patterns, I referenced Tickeron’s AI Trend Prediction Engine for additional context.

2026 Outlook and What Investors Should Watch

The July 29 earnings report represents the single most important near-term catalyst for Microsoft. Analysts expect revenue of approximately $87.4 billion and EPS of $4.21, but the market's real focus will be on fiscal 2027 capital expenditure guidance. A figure near $220 billion would be viewed as disciplined and manageable; anything materially higher risks amplifying free cash flow concerns that have weighed on the stock all year. Azure growth—guided at 39-40% constant currency—must hold that range to validate the thesis that infrastructure spending is generating proportionate returns.

Beyond earnings, investors should monitor Copilot seat growth. With Microsoft 365 Copilot now built into the business version of the productivity suite as of July 1, adoption metrics over the next two quarters will either confirm or challenge the bull case. Morgan Stanley projects Copilot seats could exceed 25 million by year-end, but the gap between 20 million paid seats and 450 million total Microsoft 365 subscribers leaves ample room for both optimism and skepticism. Macroeconomic risks, including elevated Treasury yields, Middle East geopolitical tensions, and potential softening in European IT budgets, add further layers of complexity. Still, Microsoft's $627 billion commercial backlog provides multi-year revenue visibility that few companies can match, and the stock's compressed valuation relative to historical averages suggests much of the near-term risk may already be priced in. I’m watching this closely for any shifts in guidance.

Exploring AI Trading Tools

In my analysis of names like this, I sometimes look at Tickeron’s Trending AI Robots page for a curated view of top-performing bots across different strategies and time horizons. It offers a practical way to see systematic approaches in action and can serve as a useful complement to fundamental research when markets feel uncertain.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSFT

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


MSFT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MSFT turned positive on July 02, 2026. Looking at past instances where MSFT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on MSFT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MSFT moved above its 50-day moving average on July 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MSFT crossed bullishly above the 50-day moving average on July 31, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MSFT advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 274 cases where MSFT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSFT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MSFT broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MSFT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.389) is normal, around the industry mean (23.996). P/E Ratio (27.847) is within average values for comparable stocks, (75.895). Projected Growth (PEG Ratio) (1.632) is also within normal values, averaging (1.870). Dividend Yield (0.007) settles around the average of (0.021) among similar stocks. P/S Ratio (11.223) is also within normal values, averaging (132.177).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 34.65B. The market cap for tickers in the group ranges from 48.8K to 3.71T. MSFT holds the highest valuation in this group at 3.71T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 4%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 19%. WETO experienced the highest price growth at 92%, while CSAI experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 92
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
MSFT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of software and harware products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
One Microsoft Way
Phone
+1 425 882-8080
Employees
228000
Web
https://www.microsoft.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.